|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||53.87 - 54.08|
|52 Week Range||43.85 - 54.61|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.11%|
In 3Q17, Novartis’s Cosentyx generated revenues of $556 million, which reflected a whopping 85% growth YoY (year-over-year) and ~13% growth QoQ.
Why is Vanguard voting against a shareholder measure on its proxy ballot that moves to stop investing in companies that "substantially contribute" to genocide?
In 1H17, Novartis's (NVS) Tafinlar & Mekinist reported revenues of around $403 million, which reflected ~25% growth on a year-over-year (or YoY) basis.
ViiV Healthcare is a global specialist company in HIV medicines. It focuses on developing and delivering advanced treatments for patients with HIV.
Alcon reported revenues of $1.52 billion for 2Q17, which was 1% higher YoY (year-over-year) than the $1.51 billion we saw in 2Q16.
International stocks have been the real winners this year courtesy of cheap valuations and improving economic growth in many parts of the world.
For fiscal 2017, Wall Street analysts have projected Fresenius Medical Care’s net profit margins to be close to 6.2%, which is a YoY decline of ~70 basis points.
Emerging markets stocks hit a rough spot last week as markets roiled by an intensifying geopolitical rift between the U.S. and North Korea. However, the saber rattling did not prompt large-scale departures ...
GSK's Vaccines business reported 16.0% growth to ~1.1 billion pounds in 2Q17, including 5.0% growth at constant exchange rates and 11.0% positive impact of foreign exchange.
BlackRock, the world’s largest asset manager, is calling investors to return to risk assets, particularly international equities, in the second half of the year.
In 1Q17, AstraZeneca’s leading sodium-glucose co-transporter 2 (or SGLT2) therapy for type-2 diabetes, Farxiga, reported revenues close to $270 million. This represents YoY growth of ~25% on a constant ...
We have highlighted the best performing international ETFs of 1H. Any of these strong momentum plays could be a compelling choice for investors heading into 2H.
The Japan Manufacturing PMI stood at 53.1 in May 2017, as compared to 52.7 in April, outperforming the preliminary market estimation of 52.0.
Learning how Harvard, Stanford and Yale invest billions could help the average individual investor with their portfolio
With the US market looking fairly expensive here are five ideas that may help you get to a more robust portfolio, particularly if you're invested mostly in US stocks at the moment.
A foundation I work with asked me to compare its performance with that of other foundations using the most recent data available. The news was quite good. This relatively small foundation (“Foundation X”) managed to beat the return averages for all size foundations and even the top 10 percentile of performance of all foundations. Yet it is the story of how it achieved this that is most compelling, as any individual or foundation can do the same.